消息面上，据和黄医药官微消息，和黄医药于2025年10月31日举行的投资者会议中分享最新关键研发和 业务进展。此次活动重点展示了和黄医药在推进创新癌症和免疫疾病治疗方面的最新进展，包括介绍其 新一代抗体靶向偶联药物 ("ATTC") 平台，以及后期管线候选药物的最新进展。 和黄医药(00013)涨超3%，截至发稿，涨2.95%，报24.46港元，成交额6552.25万港元。 据介绍，和黄医药ATTC平台首个候选药物HMPL-A251是一种PAM-HER2 ATTC，由高选择性、强效的 PI3K/PIKK抑制剂作为有效载荷和人源化抗HER2 IgG1抗体通过可裂解的连接子 (linker) 偶联而成。其 临床前数据近期已于2025年AACR-NCI-EORTC分子靶向和癌症治疗国际会议上公布。公司表示，从 2025年底开始推动HMPL-A251进入临床开发。初期研究将评估该候选药物在伴有不同HER2及PAM改变 状态的多个瘤种中的表现。 ...

【环球网科技综合报道】11月4日消息，据外媒报道，OpenAI已与亚马逊云服务（AWS）签署一项总额 高达380亿美元的算力资源采购协议。这一合作被视为其减少对微软依赖、构建多元化技术生态的重要 战略举措。 来源：环球网 根据协议内容，OpenAI将立即启动在AWS基础设施上的工作负载部署，初期将依托美国地区数十万台 英伟达高性能图形处理器（GPU）构建算力集群，并计划在未来数年内持续扩大资源规模，以满足其不 断增长的模型训练与推理需求。 作为估值已突破5000亿美元的AI独角兽，OpenAI此前长期与微软保持深度合作，后者不仅是其核心投 资者，还通过Azure云平台为其提供算力支持。然而，此次与AWS的签约被业界视为OpenAI"去单一 化"的关键信号。 OpenAI在声明中透露，初期部署的英伟达GPU集群将重点支持其多模态大模型研发及实时推理服务， 而后续扩容计划则暗示了该公司对AI技术商业化落地的雄心。随着自动驾驶、机器人、医疗诊断等高 算力需求场景的拓展，全球AI产业对基础设施的依赖度将持续攀升，此次合作或成为行业资源整合的 新范式。（青山） ...

Core Viewpoint - Yum China (09987) shares rose over 3%, currently up 3.13% at HKD 349.6, with a trading volume of HKD 207 million [1] Group 1: Financial Performance - Yum China is set to release its Q3 2025 financial results after the Hong Kong market closes on November 4 [1] - Nomura's recent report anticipates that the company's business will continue to show resilience, maintaining a stable fundamental outlook, with a target of single-digit percentage growth in system sales for the second half of the year [1] Group 2: Product Innovation and Customer Engagement - The company is enhancing customer loyalty through product innovation and cultural relevance, exemplified by KFC's limited edition "Pinh Hao Fan" Huang Men Ji Fan launched in late August, priced at RMB 14.9, which sparked a consumer frenzy [1] - Yum China's brands are collaborating with various IPs to penetrate different consumer demographics [1]

Core Insights - The Hang Seng Tech Index experienced fluctuations, with major ETFs reflecting similar trends, particularly in the A-share market [1] - Baidu's autonomous driving service, "Luobo Kuaipao," achieved a significant milestone by surpassing 250,000 weekly orders, marking a shift towards large-scale commercial operations in the autonomous driving sector [1][2] - The total service order volume for Luobo Kuaipao exceeded 17 million, with autonomous vehicles covering over 240 million kilometers, demonstrating the technology's reliability and adaptability in complex urban environments [1] Company Developments - Baidu's Luobo Kuaipao has successfully entered the European market, specifically Switzerland, which is known for its stringent technology, safety, and regulatory standards [2] - This entry into the European market is seen as a significant endorsement of the maturity and reliability of Chinese autonomous driving technology [2] - The Hang Seng Tech Index ETF (513180) includes 30 leading tech companies in Hong Kong, focusing on the AI industry chain, with potential key players like Alibaba, Tencent, Xiaomi, Meituan, and SMIC [2]

11月4日上午，港股百度集团一度涨超6%。公司旗下自动驾驶出行服务平台萝卜快跑公布，截至10月31 日，萝卜快跑每周订单量超过25万宗，且100%为全无人订单。 ...

(责任编辑：宋政 HN002) 【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容 的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱： news_center@staff.hexun.com 格隆汇11月4日｜印度最大线上券商Groww的母公司Billionbrains Garage Ventures将于周二启动IPO投资 者认购，预计募集资金可达663亿卢比(约7.47亿美元)。该公司将于周五前发售股票，定价区间为每股95 至100卢比，若以上限定价计算，公司估值将高达约70亿美元。股票预计将于11月12日开始交易。作为 印度版的Robinhood，Groww得到了微软首席执行官纳德拉的支持。过去几年，公司客户数量激增，截 至9月活跃用户接近1200万。此次发行正值印度IPO市场繁荣之际，10月份刚创下单月历史新高。按价 格区间上限计算，Groww的估值约为截至3月财年的收益的30倍。 ...

智通财经APP获悉，百胜中国(09987)涨超3%，截至发稿，涨3.13%，报349.6港元，成交额2.07亿港元。 消息面上，百胜中国此前宣布将于11月4日港股盘后发布2025年第三季度财务业绩。野村近期研报指 出，预期公司业务持续保持强韧，稳健基本面前景未变，仍有望实现下半年系统销售额中单位数百分比 增长目标。报告指，百胜中国持续透过产品创新及文化关联，提升客户忠诚度，例如肯德基8月底推出 限量拼好饭特供版黄焖鸡饭，每份定价14.9元人民币，引发消费热潮，旗下品牌亦与多个IP合作，渗透 至不同消费群体。 ...

（文章来源：每日经济新闻） 每经AI快讯，HSSP INTL(03626.HK)跌超22%，截至发稿，跌22.22%，报2.59港元，成交额1224.49万港 元。 ...

每经AI快讯，和黄医药(00013.HK)涨超3%，截至发稿，涨2.95%，报24.46港元，成交额6552.25万港 元。 （文章来源：每日经济新闻） ...

Core Insights - The China Banking Association released the 2025 "Gyroscope" evaluation results for commercial banks, with Luzhou Bank achieving a comprehensive score of 83.37, ranking 14th among 76 participating city commercial banks, an improvement of one position from the previous year [1] - Luzhou Bank excelled particularly in the subcategories of "Employee Awareness Capability" and "Competitive Capability," ranking 5th and 8th respectively, demonstrating strong growth momentum and resilience [1] - The "Gyroscope" evaluation system assesses commercial banks across nine dimensions, including corporate governance, risk management, and operational management, serving as a key benchmark for measuring comprehensive strength and high-quality development [1] - Since 2021, Luzhou Bank has consistently improved its overall ranking in this evaluation, reflecting its excellent management capabilities in a complex economic environment [1] - This achievement is attributed to Luzhou Bank's ongoing strategic transformation, optimization of asset structure, and enhancement of service efficiency, marking a significant step forward in its high-quality development journey [1]